{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:32:28Z","timestamp":1774463548957,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jjcc.2020.12.004","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T09:05:41Z","timestamp":1608714341000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: Start with what is right rather than what is acceptable"],"prefix":"10.1016","volume":"78","author":[{"given":"Masato","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raisuke","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2020.12.004_bib0001","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.jacc.2017.02.029","article-title":"Bleeding-related deaths in relation to the duration of dual-antiplatelet therapy after coronary stenting","volume":"69","author":"Palmerini","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0002","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0003","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0005","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1160\/TH11-04-0214","article-title":"Current antithrombotic treatment in East Asia: some perspectives on anticoagulation and antiplatelet therapy","volume":"107","author":"Ma","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0006","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.STR.31.4.817","volume":"31","author":"Yamaguchi","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008307","article-title":"CREDO-Kyoto PCI\/CABG registry cohort-2 investigators. Application of the academic research consortium high bleeding risk criteria in an all-comers registry of percutaneous coronary intervention","volume":"12","author":"Natsuaki","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0008","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4244\/EIJ-D-20-00052","article-title":"Validation of bleeding risk criteria (ARC-HBR) in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores","volume":"16","author":"Ueki","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0009","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.jacc.2020.03.070","article-title":"Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients","volume":"75","author":"Cao","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0010","article-title":"High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the pendulum Registry","author":"Nakamura","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0011","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1253\/circj.CJ-19-1109","article-title":"JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease","volume":"84","author":"Nakamura","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0012","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0013","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0014","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0016","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.jacc.2018.09.013","article-title":"Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ultimate trial","volume":"72","author":"Zhang","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0017","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCINTERVENTIONS.113.000412","article-title":"Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment\u2013elevation myocardial infarction","volume":"7","author":"Philip","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0018","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","article-title":"Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (examination): 1 year results of a randomised controlled trial","volume":"380","author":"Sabate","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0019","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/eurheartj\/ehz593","article-title":"Temporal trends in bleeding events in acute myocardial infarction: insights from the swedeheart registry","volume":"41","author":"Simonsson","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0020","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/eurheartj\/ehy807","article-title":"Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial","volume":"40","author":"Chao","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0038-1676545","article-title":"Racial differences in ischaemia\/bleeding risk trade-off during anti-platelet therapy: individual patient level landmark meta-analysis from seven RCTs","volume":"119","author":"Kang","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0022","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ahj.2008.08.031","article-title":"Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and lschemic Stabilization, Management, and Avoidance (charisma) study","volume":"157","author":"Mak","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0023","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrcardio.2014.104","article-title":"Expert consensus document: world heart federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI","volume":"11","author":"Levine","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0024","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(20)31791-8","article-title":"Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (host-reduce-polytech-ACS): an open-label, multicentre, non-inferiority randomised trial","volume":"396","author":"Kim","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0025","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/CIRCULATIONAHA.119.041766","article-title":"Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized clinical trial","volume":"140","author":"Park","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0026","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome\u2014Randomized, double-blind, phase III PHILO study","volume":"79","author":"Goto","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0027","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1253\/circj.CJ-13-1482","article-title":"Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome\u2013the PRASFIT-ACS study \u2013","volume":"78","author":"Saito","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0028","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-009-0737-1","article-title":"The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects","volume":"66","author":"Small","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0029","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5414\/CP202017","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of single and multiple doses of ticagrelor in Japanese and Caucasian volunteers","volume":"52","author":"Teng","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0030","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/j.1538-7836.2006.02237.x","article-title":"Plasma hemostatic factors and endothelial markers in four racial\/ethnic groups: the MESA study","volume":"4","author":"Lutsey","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0031","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","article-title":"Seven haemostatic gene polymorphisms in coronary disease: meta\u2011analysis of 66,155 cases and 91,307 controls","volume":"367","author":"Ye","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0032","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2010.07.002","article-title":"First direct comparison of platelet reactivity and thrombolytic status between Japanese and Western volunteers: possible relationship to the \u201cJapanese paradox","volume":"152","author":"Gorog","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0033","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1373\/clinchem.2007.098996","article-title":"Ethnic differences in C\u2011reactive protein concentrations","volume":"54","author":"Kelley-Hedgepeth","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0034","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jacc.2016.02.064","article-title":"Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS","volume":"67","author":"Baber","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0035","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0036","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0037","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0038","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jjcc.2016.05.003","article-title":"Incidence and predictors of bleeding complications after percutaneous coronary intervention","volume":"69","author":"Numasawa","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011017","article-title":"Comparison of outcomes after percutaneous coronary intervention in elderly patients, including 10 628 nonagenarians: insights from a Japanese Nationwide Registry (J-PCI Registry)","volume":"8","author":"Numasawa","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0040","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1253\/circj.CJ-19-0494","article-title":"Long-term incidence and details of bleeding events after everolimus-eluting stent implantation\u2015 7\u20138-year outcomes \u2015","volume":"83","author":"Miura","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0041","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1253\/circj.CJ-18-0956","article-title":"Prasugrel for Japanese patients with ischemic heart disease in long-term clinical practice (PRASFIT-Practice II): a 3-month interim analysis of a postmarketing observational study","volume":"83","author":"Nakamura","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0042","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1253\/circj.CJ-19-0645","article-title":"Prasugrel for Japanese patients with ischemic heart disease in long-term clinical practice (PRASFIT-Practice II): 1-year follow-up results of a postmarketing observational study","volume":"84","author":"Nakamura","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0043","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0044","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.2020.12443","article-title":"Effect of genotype-guided oral P2Y12 inhibitor selection vs conventional clopidogrel therapy on ischemic outcomes after percutaneous coronary intervention: the TAILOR-PCI Randomized Clinical Trial","volume":"324","author":"Pereira","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0045","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 Randomized Clinical Trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0046","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0047","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/CIRCULATIONAHA.120.046251","article-title":"The safety and efficacy of aspirin discontinuation on a background of a P2Y12 inhibitor in patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"142","author":"O'Donoghue","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0048","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1161\/CIRCULATIONAHA.119.043613","article-title":"Very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 Trial","volume":"140","author":"Watanabe","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0049","doi-asserted-by":"crossref","DOI":"10.1253\/circj.CJ-20-0786","article-title":"Monotherapy with prasugrel after dual antiplatelet therapy for Japanese percutaneous coronary intervention patients with high bleeding risk: a prospective cohort study (PENDULUM mono study)","author":"Nakamura","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12928-019-00626-5","article-title":"Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography","volume":"35","author":"Fujii","year":"2020","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jjcc.2020.12.004_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12928-019-00625-6","article-title":"Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese association of cardiovascular intervention and therapeutics","volume":"35","author":"Saito","year":"2020","journal-title":"Cardiovasc Interv Ther"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508720304007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508720304007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:04:46Z","timestamp":1760274286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508720304007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0914508720304007"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2020.12.004","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: Start with what is right rather than what is acceptable","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2020.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}